Brexit raises the risk of dangerous delays in the supply of medicines
More clarity is needed about how the supply of medicines might be affected by a ‘no deal’ Brexit
With the UK due to leave the European Union (EU) on 29 March next year, issues about medicines are starting to emerge.
When new health and social care secretary Matt Hancock appeared before the Commons health and social care select committee at the end of July, he said NHS England was working with industry on options regarding the potential need to stockpile medicines and blood products in case of a ‘no deal’ Brexit.
Delays in obtaining some medicines could cause patients discomfort or irritation, but for other medicines the delays could be serious, even life-threatening, so this appears to be a good idea.
Seamless supply
On 23 August, Mr Hancock wrote to health and care providers to inform them of
...Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Standard
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests
This article is not available as part of an institutional subscription. Why is this?
